Bioventix Financials

BVXP Stock   2,695  80.00  2.88%   
We suggest to use Bioventix fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Bioventix is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to interpolate and collect twenty-nine available fundamental indicators for Bioventix, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Bioventix to be traded at 2587.2 in 90 days. Key indicators impacting Bioventix's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income6.3 M12.2 M
Way Down
Slightly volatile
  
Understanding current and past Bioventix Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioventix's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioventix's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Bioventix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioventix. Check Bioventix's Beneish M Score to see the likelihood of Bioventix's management manipulating its earnings.

Bioventix Stock Summary

Bioventix competes with Zurich Insurance, Gear4music (Holdings), Jade Road, Lendinvest PLC, and Bank of Ireland. Bioventix is entity of United Kingdom. It is traded as Stock on LSE exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUK Stock View All
ExchangeLondon Exchange
ISINGB00B4QVDF07
Business Address7 Romans Business
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.bioventix.com
Phone44 12 5272 8001
You should never invest in Bioventix without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bioventix Stock, because this is throwing your money away. Analyzing the key information contained in Bioventix's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Bioventix Key Financial Ratios

There are many critical financial ratios that Bioventix's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioventix reports annually and quarterly.

Bioventix Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets12.9M13.1M13.3M13.7M15.8M8.2M
Other Current Liab315.9K385.8K412.7K375.1K431.3K452.9K
Accounts Payable150.9K157.3K77.7K170.0K195.5K205.3K
Cash6.5M6.1M5.7M6.0M6.9M4.3M
Net Receivables638.1K754.0K1.2M6.2M7.1M7.5M
Inventory332.5K461.8K565.4K615.3K707.6K743.0K
Other Current Assets3.0M4.0M4.5M4.6M5.3M5.6M
Total Liab1.1M1.3M1.2M1.7M2.0M2.1M
Common Stock257.1K260.4K260.5K261.0K300.1K223.0K
Retained Earnings10.2M10.2M10.3M10.3M11.8M7.3M
Net Debt(6.5M)(6.1M)(5.7M)(6.0M)(5.4M)(5.7M)
Total Current Assets11.5M11.8M12.1M12.8M14.8M9.5M
Net Tangible Assets10.8M12.5M11.8M11.8M13.6M10.8M
Other Liab30.9K50.2K78.1K44.3K50.9K39.1K
Net Invested Capital11.8M11.8M12.1M12.0M13.8M12.7M
Net Working Capital10.4M10.6M10.9M11.1M12.8M11.5M

Bioventix Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(87.0K)(129.4K)(103.6K)(50.0K)(45.0K)(47.2K)
Change In Cash(1.6M)(368.3K)(410.8K)283.1K254.8K265.7K
Free Cash Flow6.1M7.5M7.9M8.5M9.8M5.0M
Depreciation135.1K143.4K129.2K113.6K130.7K84.2K
Other Non Cash Items220.1K184.8K36.7K718.1K825.8K867.1K
Dividends Paid(7.7M)(7.9M)(8.4M)(8.2M)(7.4M)(7.1M)
Capital Expenditures260.3K11.8K10.6K15.9K18.3K17.4K
Net Income6.7M7.7M8.4M8.1M9.3M5.2M
End Period Cash Flow6.5M6.1M5.7M6.0M6.9M5.6M
Investments(229.2K)(7.0K)90.5K186.1K214.0K224.7K
Change To Netincome(4.4K)(65.7K)475.0K391.3K450.0K472.5K

Bioventix Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioventix's current stock value. Our valuation model uses many indicators to compare Bioventix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioventix competition to find correlations between indicators driving Bioventix's intrinsic value. More Info.
Bioventix is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bioventix is roughly  1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioventix's earnings, one of the primary drivers of an investment's value.

Bioventix Systematic Risk

Bioventix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioventix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Bioventix correlated with the market. If Beta is less than 0 Bioventix generally moves in the opposite direction as compared to the market. If Bioventix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioventix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioventix is generally in the same direction as the market. If Beta > 1 Bioventix moves generally in the same direction as, but more than the movement of the benchmark.

Bioventix Total Assets Over Time

Bioventix March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Bioventix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioventix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioventix based on widely used predictive technical indicators. In general, we focus on analyzing Bioventix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioventix's daily price indicators and compare them against related drivers.

Additional Tools for Bioventix Stock Analysis

When running Bioventix's price analysis, check to measure Bioventix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventix is operating at the current time. Most of Bioventix's value examination focuses on studying past and present price action to predict the probability of Bioventix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventix's price. Additionally, you may evaluate how the addition of Bioventix to your portfolios can decrease your overall portfolio volatility.